Egalet
Pharmaceutical company developing proprietary;abuse-deterrent products for the treatment of pain and in other indications
Egalet has raised €18M across 2 funding rounds from 3 investors, most recently a Growth/Late round in Sep 2013. Based in Denmark; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€18M
€18,377,579
Funding rounds
2
Investors
3
distinct backers
Active since
2012-05
latest 2013-09
Funding by year
EUR raised per yearEgalet — funding by year — interactive chart.
Data table
| Egalet — funding by year | |
|---|---|
| 2012 | €11M |
| 2013 | €7.6M |
Signals
High confidenceRaise-next likelihood6
base rate 37% for Growth/Late
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2013-09-01 | Growth/Late | €7.6M | Index Ventures | View deal → |
| 2012-05-01 | Series B | €11M | Atlas Venture,Index Ventures,Sunstone Capital | View deal → |
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData